| Eosinophilic granulomatosis with polyangiitis (Churg‐Strauss): clinical characteristics and long‐term followup of the 383 patients enrolled in the French Vasculitis Study Group … C Comarmond, C Pagnoux, M Khellaf, JF Cordier, M Hamidou, JF Viallard, ... Arthritis & Rheumatism 65 (1), 270-281, 2013 | 903 | 2013 |
| Azathioprine or methotrexate maintenance for ANCA-associated vasculitis C Pagnoux, A Mahr, MA Hamidou, JJ Boffa, M Ruivard, JP Ducroix, ... New England Journal of Medicine 359 (26), 2790-2803, 2008 | 763 | 2008 |
| Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule, C Guillaud, E Fois, ... Bmj 369, 2020 | 497 | 2020 |
| Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France T Lequerré, P Quartier, D Rosellini, F Alaoui, M De Bandt, O Mejjad, ... Annals of the rheumatic diseases 67 (3), 302-308, 2008 | 461 | 2008 |
| Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase 2 study B Godeau, R Porcher, O Fain, F Lefrère, P Fenaux, S Cheze, A Vekhoff, ... Blood, The Journal of the American Society of Hematology 112 (4), 999-1004, 2008 | 356 | 2008 |
| Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group F Rodeghiero, M Michel, T Gernsheimer, M Ruggeri, V Blanchette, ... Blood, The Journal of the American Society of Hematology 121 (14), 2596-2606, 2013 | 268 | 2013 |
| No evidence of clinical efficacy of hydroxychloroquine in patients hospitalised for COVID-19 infection and requiring oxygen: results of a study using routinely collected data … M Mahévas, VT Tran, M Roumier, A Chabrol, R Paule, C Guillaud, ... medrxiv, 2020.04. 10.20060699, 2020 | 256 | 2020 |
| Assessment of a therapeutic strategy for adults with severe autoimmune thrombocytopenic purpura based on a bleeding score rather than platelet count M Khellaf, M Michel, A Schaeffer, P Bierling, B Godeau Haematologica 90 (6), 829-832, 2005 | 231 | 2005 |
| B cell depletion in immune thrombocytopenia reveals splenic long-lived plasma cells M Mahévas, P Patin, F Huetz, M Descatoire, N Cagnard, C Bole-Feysot, ... The Journal of clinical investigation 123 (1), 2012 | 204 | 2012 |
| Autoimmune thrombocytopenic purpura and Helicobacter pylori infection M Michel, M Khellaf, L Desforges, K Lee, A Schaeffer, B Godeau, ... Archives of internal medicine 162 (9), 1033-1036, 2002 | 201 | 2002 |
| Safety and efficacy of rituximab in adult immune thrombocytopenia: results from a prospective registry including 248 patients M Khellaf, A Charles-Nelson, O Fain, L Terriou, JF Viallard, S Cheze, ... Blood, The Journal of the American Society of Hematology 124 (22), 3228-3236, 2014 | 198 | 2014 |
| Characteristics and outcome of warm autoimmune hemolytic anemia in adults: new insights based on a single‐center experience with 60 patients M Roumier, V Loustau, C Guillaud, L Languille, M Mahevas, M Khellaf, ... American journal of hematology 89 (9), E150-E155, 2014 | 175 | 2014 |
| Effect of the pulmonary embolism rule-out criteria on subsequent thromboembolic events among low-risk emergency department patients: the PROPER randomized clinical trial Y Freund, M Cachanado, A Aubry, C Orsini, PA Raynal, ... Jama 319 (6), 559-566, 2018 | 169 | 2018 |
| Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome O Lambotte, M Khellaf, H Harmouche, B Bader-Meunier, V Manceron, ... Medicine 85 (3), 169-182, 2006 | 162 | 2006 |
| The temporary use of thrombopoietin‐receptor agonists may induce a prolonged remission in adult chronic immune thrombocytopenia. Results of a French observational study M Mahévas, O Fain, M Ebbo, F Roudot‐Thoraval, N Limal, M Khellaf, ... British journal of haematology 165 (6), 865-869, 2014 | 155 | 2014 |
| Rituximab for induction and maintenance treatment of ANCA-associated vasculitides: a multicentre retrospective study on 80 patients P Charles, A Neel, N Tieulie, A Hot, G Pugnet, O Decaux, I Marie, ... Rheumatology 53 (3), 532-539, 2014 | 152 | 2014 |
| Long‐term outcomes among participants in the WEGENT trial of remission‐maintenance therapy for granulomatosis with polyangiitis (Wegener's) or microscopic polyangiitis X Puéchal, C Pagnoux, É Perrodeau, M Hamidou, JJ Boffa, X Kyndt, ... Arthritis & rheumatology 68 (3), 690-701, 2016 | 145 | 2016 |
| Romiplostim safety and efficacy for immune thrombocytopenia in clinical practice: 2-year results of 72 adults in a romiplostim compassionate-use program M Khellaf, M Michel, P Quittet, JF Viallard, M Alexis, F Roudot-Thoraval, ... Blood, The Journal of the American Society of Hematology 118 (16), 4338-4345, 2011 | 141 | 2011 |
| Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus M Jallouli, L Galicier, N Zahr, O Aumaitre, C Frances, V Le Guern, F Lioté, ... Arthritis & rheumatology 67 (8), 2176-2184, 2015 | 138 | 2015 |
| Delayed hemolytic transfusion reaction in adult sickle‐cell disease: presentations, outcomes, and treatments of 99 referral center episodes A Habibi, A Mekontso‐Dessap, C Guillaud, M Michel, K Razazi, M Khellaf, ... American Journal of Hematology 91 (10), 989-994, 2016 | 122 | 2016 |
Pablo BartolucciUPEC, APHP, INSERM IMRB, Label GRex在 aphp.fr 的电子邮件经过验证
